isoflurane has been researched along with Cardiometabolic Syndrome in 1 studies
Isoflurane: A stable, non-explosive inhalation anesthetic, relatively free from significant side effects.
Cardiometabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components not only include metabolic dysfunctions of METABOLIC SYNDROME but also HYPERTENSION, and ABDOMINAL OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Morbid obesity affects the pharmacokinetics and pharmacodynamics of anesthetics, which may result in inappropriate dosing." | 5.38 | Determination of minimum alveolar concentration for isoflurane and sevoflurane in a rodent model of human metabolic syndrome. ( Britton, SL; Koch, LG; Lipinski, WJ; Lydic, R; Mashour, GA; Pal, D; Walton, ME, 2012) |
| "Morbid obesity affects the pharmacokinetics and pharmacodynamics of anesthetics, which may result in inappropriate dosing." | 1.38 | Determination of minimum alveolar concentration for isoflurane and sevoflurane in a rodent model of human metabolic syndrome. ( Britton, SL; Koch, LG; Lipinski, WJ; Lydic, R; Mashour, GA; Pal, D; Walton, ME, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pal, D | 1 |
| Walton, ME | 1 |
| Lipinski, WJ | 1 |
| Koch, LG | 1 |
| Lydic, R | 1 |
| Britton, SL | 1 |
| Mashour, GA | 1 |
1 other study available for isoflurane and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Determination of minimum alveolar concentration for isoflurane and sevoflurane in a rodent model of human metabolic syndrome.
Topics: Administration, Inhalation; Anesthetics, Inhalation; Animals; Behavior, Animal; Disease Models, Anim | 2012 |